New product [Regulatives / Guidelines]

posted by Ohlbe – France, 2020-03-11 18:54 (1941 d 22:01 ago) – Posting: # 21257
Views: 6,214

Dear SKM,

❝ Both the APIs are registered and marketed as separate formulation. We are mixing these two at same ratio into one formulation without adding any new excipients. I don't know why will it be considered as a new product. Can you guide me please?


Well, you are giving all the arguments yourself: up to now the two active substances are only marketed as separate formulations. You will be mixing them into one new formulation, which has never been tested or marketed before. Sorry, but I can't explain more.

Regards
Ohlbe

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,686 registered users;
45 visitors (0 registered, 45 guests [including 10 identified bots]).
Forum time: 17:56 CEST (Europe/Vienna)

In the field of observation,
chance favors only the mind that is prepared.    Louis Pasteur

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5